Trials / Completed
CompletedNCT00761137
Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients
A Two-Phase, Double Blind, Placebo-Controlled, Randomized, Crossover Study of the Safety and Efficacy of Intra-Oral NH004 Films for the Short-Term Relief of Sialorrhea Symptoms in Parkinson's Disease Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- NeuroHealing Pharmaceuticals Inc. · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary goal of the study is to evaluate the safety and potential efficacy of intra-oral dissolvable NH004 films to improve the short-term symptoms of sialorrhea (drooling) in Parkinson's disease (PD) patients.
Detailed description
NH004 contains the anticholinergic agent tropicamide and is delivered in a convenient product form (intra-oral dissolvable thin films) designed for the management of sialorrhea. This study is a double blind, placebo-controlled, crossover study of the safety and potential efficacy of three doses of of NH004 films for the short-term relief of the symptoms of sialorrhea in Parkinson's disease patients. A total of up to 36 Parkinson's disease patients will be enrolled in the study in two Phases. Phase A will include 12 patients and Phase B up to 24 patients. There will be an interim analysis after conclusion of Phase A. In both phases patients will be randomized into one of four groups. Each group will have a distinctive sequence for receiving intra-oral dissolvable films of 0.3 mg, 1 mg, 3 mg of NH004, or placebo during four visits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.3 mg tropicamide | 0.3 mg tropicamide in intra-oral thin film |
| DRUG | 1 mg tropicamide | 1 mg tropicamide in intra-oral thin film |
| DRUG | 3 mg tropicamide | 3 mg tropicamide in intra-oral thin film |
| DRUG | 0 mg tropicamide | 0 mg tropicamide (placebo) in intra-oral thin film |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2008-09-29
- Last updated
- 2015-10-12
- Results posted
- 2015-10-12
Locations
1 site across 1 country: Argentina
Source: ClinicalTrials.gov record NCT00761137. Inclusion in this directory is not an endorsement.